Low doses of oral fludarabine in previously untreated elderly patients affected by chronic lymphocytic leukemia: Experience of a single unit

被引：0
|
作者：
Quirino, A. A. [1 ]
Villa, M. R. [1 ]
Improta, S. [1 ]
Lucania, A. [1 ]
Sagristani, M. [1 ]
Correale, F. [1 ]
Mastrullo, L. [1 ]
机构：
[1] PO San Gennaro, ASL NA1, UOC Ematol, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [31] High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia
    Cazin, Bruno
    Divine, Marine
    Lepretre, Stephane
    Travade, Philippe
    Tournilhac, Olivier
    Delmer, Alain
    Jaubert, Jerome
    Feugier, Pierre
    Dreyfus, Brigitte
    Mahe, Beatrice
    Grosbois, Bernard
    Maloisel, Frederic
    Eghbali, Houchingue
    Dumontet, Charles
    Benichou, Jacques
    Guibon, Odile
    Leleu, Xavier
    Leporrier, Michel
    Maloum, Karim
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (01) : 54 - 59
  • [32] Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
    Chen, Christine I.
    Bergsagel, P. Leif
    Paul, Harminder
    Xu, Wei
    Lau, Anthea
    Dave, Nimisha
    Kukreti, Vishal
    Wei, Ellen
    Leung-Hagesteijn, Chungyee
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Johnston, James
    Gibson, Spencer
    Hernandez, Tiffany
    Spaner, David
    Trudel, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1175 - 1181
  • [33] Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia
    Hornberger, John
    Reyes, Carolina
    Shewade, Ashwini
    Lerner, Susan
    Friedmann, Mark
    Han, Leona
    Gutierrez, Hialy
    Satram-Hoang, Sacha
    Keating, Michael J.
    LEUKEMIA & LYMPHOMA, 2012, 53 (02) : 225 - 234
  • [34] Cost-effectiveness of rituximab, fludarabine, and cyclophosphamide (R-FC) in patients with previously untreated chronic lymphocytic leukemia (CLL)
    Hornberger, J. C.
    Reyes, C. M.
    Shewade, A.
    Friedmann, M.
    Chan, L.
    Gutierrez, H.
    Satram-Hoang, S.
    Lerner, S.
    Keating, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
    Nicole Lamanna
    Mark A. Weiss
    Current Hematologic Malignancy Reports, 2009, 4 (4) : 185 - 186
  • [36] Fludarabine and cyclophosphamide achieves high complete response rate in patients with previously untreated chronic lymphocytic leukemia: ECOG 1997.
    Flinn, IW
    Jemiai, Y
    Bennett, JM
    Falkson, CI
    Flynn, P
    Pundaleeka, S
    Stadtmauer, E
    Schnell, F
    Grever, M
    Tallman, MS
    Rowe, JM
    BLOOD, 2001, 98 (11) : 633A - 633A
  • [37] Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study
    Leblond, Veronique
    Cantin, Guy
    Cortelezzi, Agostino
    Knauf, Wolfgang
    Tiab, Mourad
    Turgut, Mehmet
    Zaritskey, Andrey
    Merot, Jean-Louis
    Trunzer, Kerstin
    Robson, Susan
    Gresko, Ekaterina
    Stilgenbauer, Stephan
    Foa, Robin
    Bosch, Francesc
    BLOOD, 2017, 130
  • [38] DEVELOPMENT OF A COMPREHENSIVE PROGNOSTIC INDEX FOR PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Pflug, N.
    Bahlo, J.
    Shanafelt, T.
    Eichhorst, B.
    Bergmann, M.
    Elter, T.
    Bauer, K.
    Malchau, G.
    Rabe, K.
    Stilgenbauer, S.
    Doehner, H.
    Jaeger, U.
    Eckart, M.
    Hopfinger, G.
    Busch, R.
    Fink, A.
    Wendtner, C.
    Fischer, K.
    Kay, N.
    Hallek, M.
    HAEMATOLOGICA, 2013, 98 : 32 - 32
  • [39] Leustatin(R) in the treatment of patients with previously untreated chronic lymphocytic leukemia.
    Tallman, MS
    Wollins, E
    Jain, V
    Schiller, G
    Shepherd, J
    Silver, R
    Peterson, L
    BLOOD, 1997, 90 (10) : 2574 - 2574
  • [40] Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective
    Owen, Carolyn J.
    Stewart, Douglas A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (04) : 161 - 170
12345